Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Long-Term Deferred Tax (2023 - 2024)

Historic Long-Term Deferred Tax for Ascendis Pharma A (ASND) over the last 2 years, with Q4 2024 value amounting to -$7.8 million.

  • Ascendis Pharma A's Long-Term Deferred Tax fell 2364.42% to -$7.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.8 million, marking a year-over-year decrease of 2364.42%. This contributed to the annual value of -$7.9 million for FY2024, which is 2523.43% down from last year.
  • As of Q4 2024, Ascendis Pharma A's Long-Term Deferred Tax stood at -$7.8 million, which was down 2364.42% from -$6.3 million recorded in Q4 2023.
  • Ascendis Pharma A's Long-Term Deferred Tax's 5-year high stood at -$6.3 million during Q4 2023, with a 5-year trough of -$7.8 million in Q4 2024.